SUBSCRIBE: Apple Podcasts | Spotify
In this episode, Dr. Morgentaler and Dr. Brandon talk about new research showing that low testosterone is linked to higher mortality in men with prostate cancer, challenging decades of belief that testosterone fuels the disease and highlighting its role as a vital factor for overall health.
- 00:23 – Early Belief: Dr. Morgentaler and Dr. Brandon talk about testosterone’s early link to prostate cancer; they also say this belief shaped medicine for decades.
- 08:45 – New Data: They talk about new data showing low testosterone ties to higher death rates; they also say it overturns old thinking.
- 15:32 – Testosterone’s Role: They talk about testosterone’s role in prostate growth; they also say cancer is rare when men are young and levels are highest.
- 18:31 – Studies: They talk about studies on testosterone and outcomes; they also say low levels are linked with worse results.
- 22:52 – The Future of Testosterone: They talk about the future of testosterone therapy; they also say keeping levels normal may support better health and survival.
Resources
D’Amico, A. V. (n.d.). Low testosterone level and mortality risk in patients with prostate cancer. [Study referenced in transcript; specific journal details not provided].
Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer: The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293–297.
